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Novel technique for generating macrophage foam cells
for in vitro reverse cholesterol transport studies
Bhaswati Sengupta, Chandrakala Aluganti Narasimhulu, and Sampath Parthasarathy1
Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32827

Supplementary key words lysophosphatidylcholine • high density lipoprotein • NBD-cholesterol

Increased plasma LDL, an important risk factor for atherosclerosis, leads to its subendothelial accumulation. In
the intima, LDL undergoes several structural and physiological modifications, mediated by oxidation, denaturation, enzyme actions, or self-aggregation (1–5). Enhanced
uptake of modified lipoproteins by macrophages involves
at least two crucial scavenger receptors, namely, scavenger
receptor class A type 1 (SR-A1) and cluster of differentiation 36 (CD36) (6, 7). In addition, fluid phase pinocytosis
of LDL has been suggested to result in foam cell formation
(8). Eventually, lesion progression and plaque rupture result in platelet aggregation and the formation of thrombus, which can lead to heart attack or stroke (9). Changes
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in lifestyle, diet, and physical exercise are known to cause
regression of atherosclerosis (10).
Reverse cholesterol transport (RCT) is a mechanism
through which cholesterol from peripheral tissues, especially
from macrophage-rich plaques, is effluxed to apolipoprotein A-I/HDL, and then transferred to liver for disposal
(11–13). It is currently believed that the cholesterol efflux capacity of HDL, and not the HDL cholesterol level,
has positive correlation with antiatherogenicity (14). However, recent studies by Hazen and associates showed a
remarkable association of RCT with increased risk for
myocardial infarction, stroke, and death. Although RCT
assay at the time of sample collection indicated cholesterol efflux activity from macrophages to apoB-depleted
serum, as cholesterol acceptor, was inversely associated
with risk of prevalent coronary artery diseases (CAD)
(15), when subjects were followed for three years, a positive correlation between increased cholesterol efflux and
increased CAD was observed. Regardless of the implications of RCT, it is obvious that RCT is an important phenomenon that requires not only further investigations
but also more efficient methods to study. Cholesterol efflux from peripheral tissues is promoted by transporters
ABCA1 and ABCG1 (16). RCT also involves uptake of
free and esterified cholesterol by hepatic HDL receptor,
scavenger receptor class B type 1 (SR-B1) (17).
HDL not only acts as an acceptor for plaque cholesterol
(18) but also has been suggested to have several antiatherogenic functionalities, such as antioxidative, anti-inflammatory,
and antithrombotic (19–21) properties. Oxidation of HDL
renders it “dysfunctional” (22, 23), and this dysfunctionality has been suggested to be an important factor in
the control of atherosclerosis. Previous studies showed

Abbreviations: ac-LDL, acetylated LDL; CD36, cluster of differentiation 36; CE, cholesteryl ester; LDH, lactate dehydrogenase; LPDS,
lipoprotein-deficient serum; lyso-PtdCho, lysophosphatidylcholine;
MPO, myeloperoxidase; ox-HDL, oxidized HDL; PtdCho, phosphatidylcholine; RBC, red blood cell; RCT, reverse cholesterol transport;
SR-A1, scavenger receptor class A type 1; SR-B1, scavenger receptor
class B type 1.
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Abstract Generation of foam cells, an essential step for
reverse cholesterol transport studies, uses the technique of
receptor-dependent macrophage loading with radiolabeled
acetylated LDL. In this study, we used the ability of a biologically relevant detergent molecule, lysophosphatidylcholine (lyso-PtdCho), to form mixed micelles with cholesterol
or cholesteryl ester (CE) to generate macrophage foam
cells. Fluorescent or radiolabeled cholesterol/lyso-PtdCho
mixed micelles were prepared and incubated with RAW
264.7 or mouse peritoneal macrophages. Results showed
that such micelles were quite stable at 4°C and retained the
solubilized cholesterol during one month of storage. Macrophages incubated with cholesterol or CE (unlabeled, fluorescently labeled, or radiolabeled)/lyso-PtdCho mixed micelles
accumulated CE as documented by microscopy, lipid staining, labeled oleate incorporation, and by TLC. Such foam
cells unloaded cholesterol when incubated with HDL but
not with oxidized HDL. We propose that stable cholesterol or CE/lyso-PtdCho micelles would offer advantages
over existing methods.—Sengupta, B., C. A. Narasimhulu,
and S. Parthasarathy. Novel technique for generating macrophage foam cells for in vitro reverse cholesterol transport
studies. J. Lipid Res. 2013. 54: 3358–3372.
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CE efficiently (35). Thus, while lyso-PtdCho would be
“de-toxified,” CE would accumulate. This process also
could be considered biological, as oxidized LDL (oxLDL) has been suggested to be involved in foam cell
formation and contains substantial levels of lyso-PtdCho
(36, 37).
NBD-cholesterol has been previously used in several
studies related to uptake, metabolism, and HDL-mediated
efflux in primary hepatocytes and fibroblasts (38, 39). In recent years NBD-cholesterol has become a significant tool
to study cholesterol metabolism because it closely mimics
the behavior of cholesterol regarding metabolism and
intracellular trafficking (40). In the present study NBDcholesterol along with a 3H-cholesterol has been used as
the analog for cholesterol to demonstrate lyso-PtdChomediated cholesterol loading, foam cell development,
and HDL-induced cholesterol efflux.

MATERIALS AND METHODS
Reagents
RPMI 1640, advanced DMEM (ADMEM), FBS, sodium pyruvate, L-glutamine, penicillin-streptomycin (PS), 1× PBS, NBDcholesterol were bought from Invitrogen Life Technologies
(Carlsbad, CA). Cholesterol, lyso-PtdCho from egg yolk, oleic acid,
0.9% saline, fucoidan, polyinosinic acid, snake venom phospholipase A2, 4-dimethylaminopyridine, and silica gel matrix for TLC
separation were purchased from Sigma-Aldrich (St. Louis, MO).
Chloroform, methyl alcohol, hexane, diethyl ether, acetic acid isopropyl alcohol, and ethyl alcohol were purchased from VWR international (Randor, PA). [1, 2-3H (N)] cholesterol, [1-14C] oleic acid,
and [methyl-14C] choline chloride were purchased from American
Radiolabeled Chemicals (St. Louis, MO). Oil Red O was purchased
from Fisher Scientific (Hampton, NH) and oleic anhydride from
Santa Cruz Biotechnology (Dallas, TX).

Cell culture
RAW 264.7 macrophages were cultured in RPMI 1640 medium
containing 10% FBS, 1% PS, 1% sodium pyruvate, and 1% Lglutamine. Cells were seeded at 1.2 × 106/ml density and incubated at 37°C in a 5% CO2 incubator to reach 65–70% confluence
overnight. For the experiments involving foam cell development,
RPMI 1640 with 0.1% lipoprotein-deficient serum (LPDS) was
used as the incubation medium. Swiss Webster mice were purchased from Charles River (Wilmington, MA) and used to collect
peritoneal macrophages. Macrophages from peritoneal cavity of
ten-week-old Swiss Webster mice were isolated by peritoneal lavage using 5 ml cold 0.9% saline, followed by centrifugation.
Cells were cultured under the same conditions as used for RAW
macrophages. HepG2 cells were cultured in ADMEM containing
10% FBS, 1% PS, and 1% L-glutamine.

Solubilization of cholesterol
Stock solutions of 5 mM cholesterol and 2 mM NBD-cholesterol
were prepared in chloroform. Lyso-PtdCho stock solution (20
mM) was prepared in chloroform:methanol (1:1). For a typical reaction, 3 µmol of cholesterol (600 µl from the stock), 10 nmol of
NBD-cholesterol (5 µl from the stock), and 3 µmol of lyso-PtdCho
(150 µl from the stock) were mixed together in a test tube, followed by drying under nitrogen. Sterile PBS (1 ml) was added to
the dried content and the mixture was vigorously vortexed for 1–2
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that oxidation of apoA-I impairs the efflux of cholesterol
and, thereby, RCT (24).
The currently available technique to study RCT in vitro
involves the use of macrophage foam cells generated by
incubation with radioactive-cholesterol-labeled ac-LDL.
Macrophages incubated with radiolabeled ac-LDL are
used as foam cells to study RCT with respect to HDL heterogeneity (25) and to investigate the role of ABCA1 in
RCT (26, 27). In recent times, a novel approach has been
taken for high-throughput cholesterol efflux studies. Macrophages incubated with radiolabeled free cholesterol
were utilized to study cholesterol efflux in presence of serum from human subjects (15, 28). Fluorescently labeled
cholesterol (NBD-cholesterol), which has the NBD probe
attached to alkyl chain of cholesterol (29), has been used
for several in vitro RCT studies. This method has been extended to study RCT in an in vivo model (30). Foam cells
loaded with radiolabeled ac-LDL were injected intraperitoneally in animal models, and then distribution of labeled
cholesterol in plasma, liver, and feces were followed and
measured (12, 31). To understand and evaluate the functionality of HDL, a speedier and more reliable assay needs
to be developed.
The current methods of labeling ac-LDL with radioactive
or fluorescent tags suffer from major deficiencies. First,
LDL has to be isolated from suitable donors, and ac-LDL
needs to be prepared. These lipoproteins are inherently unstable and their shelf life is limited. Our previous studies
have demonstrated that LDL undergoes oxidation even
during the centrifugation involved in its preparation (1).
Longer dialysis and other steps also promote oxidation, and
such particles have to be stored with EDTA or other additives. Acetylation involves toxic chemicals, such as acetic anhydride, and additional dialysis steps are involved in its
isolation. The incorporation of radioactive/fluorescent tags
involves physical adsorption methods and another purification step to remove unincorporated tracers. In addition,
there is variability in the extent of cholesterol incorporation
into different preparations of ac-LDL that might offer inconsistent information regarding RCT when cholesterol efflux data from different patients are compared.
Thus, there is a need for an efficient method for incorporation of cholesterol into macrophages. Past studies from our laboratory demonstrated that a highly
nonpolar molecule, ␤-carotene, could be very efficiently
solubilized using lyso-PtdCho as a natural “detergent.”
The resulting solution was optically clear and stable, and
it provided an opportunity to enrich cellular ␤-carotene in
a concentration-dependent manner (32). In this study,
we use a similar technique to incorporate cholesterol or
cholesteryl ester (CE) into macrophages to generate foam
cells. lyso-PtdCho is very efficiently utilized by macrophages by different ways: i) an acyltransferase reaction
yields phosphatidylcholine (PtdCho) from lyso-PtdCho;
ii) lyso phospholipase cleaves the acyl ester bond and
removes the detergent nature of lyso-PtdCho; and iii) intermolecular transesterification reaction creates a molecule of PtdCho and glycerophosphorylcholine (33, 34). In
contrast, macrophages esterify cholesterol and accumulate
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min. The aqueous solution was filtered through 0.22 µm filter. The
entire procedure was done under semidarkness.
In studies with radioactive cholesterol, NBD-cholesterol was
3
substituted with H-cholesterol to give a final specific radioactivity of 5,000 DPM/nmol of cholesterol.

Synthesis of fluorescent CE
Two milligrams of cholesterol, 0.2 mg NBD-cholesterol, and
25 mg oleic anhydride were mixed and dried in a glass tube. Then
4-dimethylaminopyridine was added to the reaction mixture as a
catalyst for esterification (41), and the whole reaction mixture was
heated at 80°C for 30 min until the liquid became bright yellow.
The presence of NBD-CE was verified by TLC, and later NBD-CE
was separated from the reaction mixture by column chromatography. Purity of NBD-CE was checked again by TLC.

Isolation and modifications of lipoproteins

Cellular uptake of cholesterol
RAW 264.7 macrophages were seeded in 12-well plates at 1.2 ×
10 cells/ml concentrations to reach 65–70% confluence overnight. Cells were washed with warm sterile PBS once, followed by
4 h of incubation with 0.1% LPDS containing RPMI 1640. After
4 h, these cells were incubated with 40 µl of cholesterol or CE/
lyso-PtdCho mixed micelle filtrate per ml of medium [equivalent
of 120 µM concentrations of lyso-PtdCho and cholesterol (or CE)
each]. For each experiment involving cholesterol (unlabeled
and NBD or 3H-cholesterol)/lyso-PtdCho mixed micelles, 40 µM
oleic acid was added to the cells during the incubation. Freshly
isolated peritoneal macrophages were seeded in 24-well plates
at 2.5 × 106 cells/ml concentrations and used in the same way to
demonstrate cholesterol uptake via cholesterol/lyso-PtdCho
mixed micelles. After overnight incubation, cells were washed
with warm PBS twice, and images of live cells were taken under
fluorescence microscope (Axio imager, Carl Zeiss AG, Oberkochen,
Germany) or cells were fixed with 10% formalin and stained with
Oil Red O.
6

Detection of foam cells
To detect the presence of fluorescent NBD-cholesterol within
the cells, images of live cells were taken with AxioCam MRm
(Axio imager, Carl Zeiss AG, Oberkochen, Germany). RAW 264.7
macrophages were then lysed by incubating with 1 ml of methanol
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Quantification of cholesterol incorporated in total
extracted lipid and in CE
Macrophages were incubated with 3H-cholesterol labeled acLDL or cholesterol (unlabeled and 3H-cholesterol)/lyso-PtdCho
mixed micelles for 18 h at 37°C. Lipid extraction was done using
the method of Bligh and Dyer (48). Lipids were dissolved in 50 µl
of chloroform, and then 5 µl of this was utilized directly to measure 3H-cholesterol incorporation. This procedure was done in
triplicate and the rest of the reconstituted lipid (ⵑ35 µl) was
used for TLC analysis. Lipids were separated by TLC on silica gel
matrix using hexane/diethyl ether/acetic acid (30:6:0.5; v/v/v)
solvent system (49) and visualized with iodine vapor. Spots of CE
from samples incubated with 3H-cholesterol labeled ac-LDL or
cholesterol (unlabeled and 3H-cholesterol)/lyso-PtdCho mixed
micelles were compared with CE standard and analyzed for 3Hcholesterol incorporation by liquid scintillation and luminescence
counters (MicroBeta2 Plate Counter, PerkinElmer, Waltham,
MA). Count per minute (CPM) values obtained for the incorporation of 3H-cholesterol in total extracted lipid or CE fraction of
lipid was converted into nanomoles of cholesterol and represented subsequently.

Incorporation of 14C-oleic acid in CE within foam cells
To demonstrate the conversion of cholesterol into CE while
using cholesterol/lyso-PtdCho mixed micelles, 14C-oleic acid
was introduced during incubation of cells with cholesterol/lysoPtdCho mixed micelles. A stock solution of 100 mM oleic acid
containing 1 µCi 14C-oleic acid was prepared. RAW 264.7 macrophages were incubated with either cholesterol/lyso-PtdCho or
CE/lyso-PtdCho mixed micelles in presence of 40 µM oleic acid/
ml of medium for 18 h. After overnight incubation, cells were
washed with warm PBS twice and lipid extraction was done with
methanol/chloroform (2:1) (48). Chloroform-lipid phase was
separated, the solvent was evaporated under nitrogen, and the
lipids were reconstituted with chloroform. Lipids were separated
and CE was identified as described previously. Spots of CE from
samples incubated with cholesterol/lyso-PtdCho or CE/lyso-PtdCho
mixed micelles were compared with CE standard and analyzed for
14
C-oleic acid incorporation by autoradiography (Cyclone Plus
Phosphor Imager, PerkinElmer, Waltham, MA) followed by liquid scintillation and luminescence counting.

Measurement of lactate dehydrogenase activity
Lactate dehydrogenase (LDH) cytotoxicity assay kit (Catalog
number 10008882) was purchased from Cayman Chemical (Ann
Arbor, MI), and the assay was performed following the protocol
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Following Institutional Review Board approval, blood was collected in heparinized tubes from consenting healthy donors and
stored on ice. Blood was centrifuged at 3,000 rpm for 20 min, and
plasma was separated. Lipoproteins were isolated from normal
plasma by sequential ultracentrifugation using a Beckman TL100 tabletop ultracentrifuge (Beckman, Palo Alto, CA) (42). The
isolated lipoproteins were dialyzed against 0.3 mM EDTA in 1×
PBS (pH 7.4) overnight and subsequently filter sterilized. The
amount of protein was estimated using the Folin Lowry method.
Lipoprotein sample was subjected to oxidation immediately after
dialysis. Oxidation of lipoproteins was performed using either
5 µM copper (Cu) or myeloperoxidase (MPO) as described previously (43, 44). LDL was acetylated using acetic anhydride (4).
Acetylated LDL (ac-LDL) was dialyzed overnight and filter sterilized using 0.2 m syringe filter. Isolated and modified lipoproteins
were stored at 4°C and used within one week of preparation.
Tagging ac-LDL with 3H-cholesterol was done as described previously by Kritharides et al. (42, 43). ac-LDL and 3H-cholesterol in
ethanol were coincubated with RPMI containing 1% LPDS for
24 h at 37°C. This stock reaction mixture was diluted to obtain a
working solution that contained 10 µg protein/ml of ac-LDL and
0.25 µCi/ml 3H-cholesterol in RPMI with 0.1% LPDS (45, 46).

at 37°C for 15 min. Cell lysates were centrifuged at 3,000 rpm for
10 min. Supernatant (100 µl) was used to measure fluorescence
intensity present within the cells. Fluorescence plate reader (Envision 2014 Multilabel Plate Reader, PerkinElmer, Waltham, MA)
was used to measure fluorescence intensity at emission spectra of
535 nm upon excitation at 475 nm.
Macrophages were also fixed to stain for CE droplets. After
washing with PBS, cells were fixed with 10% formalin, made permeable with 60% isopropanol, and stained with Oil Red O. Images
of foam cells were taken under 10× and 40× objectives in the light
microscope with the Leica DFC295 camera (Leica Camera AG,
Solms, Germany). Oil Red O-stained lipid droplets were further
quantified by elution of the stain, followed by absorption measurement with a spectrophotometer. Stained wells were rinsed with
60% isopropanol very briefly to remove any residual Oil Red O
and then dried completely. Stains were eluted with 1 ml isopropanol for 10 min at room temperature. After thorough pipetting to
ensure complete elution, 100 µl aliquots were taken in triplicates
in a 96-well plate, and absorbance was measured at 500 nm (47).
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supplied with the kit. In brief, RAW 264.7 macrophages were
seeded at from 105 to 106 density in 96-well plates. After treating
the cells for 18 h, 100 µl of medium was collected from each of
the well and NAD+ (provided with the kit) was added to the medium. Enzymatic activity of LDH oxidized lactate into pyruvate
and converted NAD+ into NADPH and H+. Finally, a colorimetric
reaction between NADPH and H+ and diaphorase (provided with
the kit) produced dark-pink formazan. Formation of formazan
was measured at 490–520 nm wavelength using a plate reader
(Benchmark Plus Microplate Spectrophotometer System, BioRad, Hercules, CA), and LDH activity per ml of medium was calculated using standard curve. All the treatments were performed
at least in triplicate and repeated four times.

were washed with PBS twice, and fresh medium was added. Cells
were then incubated with 0–200 µg/ml of native HDL or 25 and
50 µg/ml of ox-HDL (MPO or Cu mediated) for 4 h, and medium was collected to measure fluorescence intensity. After removal of the medium, RAW 264.7 macrophages were washed
with PBS, and images under fluorescence microscope were taken.
To measure fluorescence intensity within the cells, cell lysates
were prepared as described before, or cells were fixed and stained
with Oil Red O to observe CE accumulation.
To study cholesterol efflux, foam cells were also developed using 3H-cholesterol (and unlabeled cholesterol)/lyso-PtdCho
mixed micelles. Efflux of 3H-cholesterol in medium upon incubation with HDL was measured by liquid scintillation and luminescence counters.

Hemolysis of human RBC

14

Synthesis of C-lyso-PtdCho and quantification of
lyso-PtdCho metabolism by macrophages
Synthesis of 14C-lyso-PtdCho was done from 14C-choline chloride. HepG2 cells were incubated with 5 µCi of 14C-choline chloride in presence of total growth medium ADMEM that contains
4 µg/ml choline chloride. After 72 h of incubation, lipids were
extracted and were separated by TLC using chloroform/methanol/
water (65: 25: 3.5; v/v/v) as the solvent system. PtdCho band was
extracted with chloroform: methanol (1:1) followed by reconstitution of dried lipid content with 0.8 ml of PBS. This reconstituted
PtdCho was subjected to enzymatic conversion into lyso-PtdCho by
adding 25 µl snake venom PLA2 (0.5 units) and 80 µl of 10 mM
CaCl2. The reaction was set at 37°C for 4 h and the reaction mixture was used to run TLC using the previous solvent system with
lyso-PtdCho and PtdCho as standards. lyso-PtdCho band from the
TLC plate was extracted and was used for further experiments.
14
C-lyso-PtdCho was mixed with 3 µmoles unlabeled lyso-PtdCho
and 3 µmoles cholesterol from the previously described stock solutions. The reaction mixture was dried under nitrogen and reconstituted with 1 ml PBS by vigorous vortexing. After filtering, 5 µl
of the micelles were used to measure radioactivity count. Cholesterol/lyso-PtdCho (unlabeled and 14C labeled) mixed micelles
containing at least 5,000 CPM/ml activity (ⵑ25 µl/ml of medium)
were used to incubate RAW 264.7 macrophages with for 18 h at
37°C. After overnight incubation, lipid extraction was done by
Bligh and Dyer method and reconstituted lipid was used to run
TLC with PtdCho and lyso-PtdCho standards using chloroform/
methanol/water (65: 25: 3.5; v/v/v) solvent system. Spots corresponding to PtdCho and lyso-PtdCho standards were isolated from
the TLC plate, and metabolic fate of 14C-lyso-PtdCho was determined by liquid scintillation and luminescence counters.

Quantification of cellular cholesterol efflux
RAW 264.7 macrophages and mouse peritoneal macrophages
incubated overnight with cholesterol/lyso-PtdCho mixed micelles

Statistical analysis
Each experiment was performed more than three times, and
each experimental condition was set up in triplicate. All values
were presented as mean ± SD. To determine the difference between two groups, unpaired two-tailed Student t-test was applied.
ANOVA (ANOVA) was applied with Dunnett’s or Bonferroni’s
correction for multiple comparisons using GraphPad Prism 5.0
software (San Diego, CA). The minimum level of significance in
all tests was P < 0.05.

RESULTS
Solubilization of cholesterol in aqueous solution in
presence of lyso-PtdCho
Cholesterol was solubilized in PBS by mixing cholesterol
and lyso-PtdCho together. To determine if lyso-PtdCho could
increase the solubility of cholesterol in PBS, constant amounts
of cholesterol, NBD-cholesterol, and an increasing amount of
lyso-PtdCho were taken in five glass tubes. After drying, aqueous solution was made with 1 ml PBS as described in Materials
and Methods. Prepared mixed micelles contained 1 mM cholesterol (200 µl from 5 mM stock) and 5 µM NBD-cholesterol
(2.5 µl from 2 mM stock) and lyso-PtdCho ranging from
0–500 µM (0, 2.5, 5, 12.5, and 25 µl from 20 mM stock). Fluorescence intensity was determined in the clear filtrate. Fluorescence intensity of the aqueous solution containing only
cholesterol and fluorescent cholesterol (but no lyso-PtdCho)
was at the background level and increased in the filtrates containing increasing amounts of lyso-PtdCho (Fig. 1A).
To determine whether cholesterol could reduce the
solubility of NBD-cholesterol in PBS in a concentrationdependent manner, increasing concentrations of cholesterol
ranging 3–24 µM (0.6, 1.2, 3.6, and 4.8 µl from 5 mM stock)
were taken in four glass tubes. Equimolar concentration of
lyso-PtdCho ranging 3–24 µM (0.15, 0.3, 0.9, and 1.2 µl from
20 mM stock) was added to the cholesterol, and a constant
concentration of 5 µM NBD-cholesterol was taken. Mixed
micelles in 1 ml of PBS were made as described above. The
fluorescence intensity of the aqueous solution gradually decreased as the concentration of unlabeled cholesterol used
to make mixed micelles increased (Fig. 1B).
Accumulation of fluorescent cholesterol in macrophages
RAW 264.7 macrophages were incubated with mixed
micelles containing increasing concentrations (0–10 µM)
Method for reverse cholesterol transport
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Human blood collected in a heparinized tube was centrifuged
at 3,000 rpm for 20 min, and RBC was collected from the pellet
and washed. RBC was diluted with 0.9% saline (1:20; v/v) and
hemolysis in presence of water was performed to determine the
optical density value equivalent to 1 and to determine the optimum volume of diluted RBC required for the rest of the experiment. Then 75 µl of diluted RBC was taken in eight glass tubes and
0, 10, 25, 50, 100, 150, 200, and 250 µM of lyso-PtdCho micelles,
cholesterol/lyso-PtdCho, and CE/lyso-PtdCho mixed micelles
were added to each tube. The volume was made up to 1 ml by adding PBS, and the reaction mixtures were incubated at room temperature for 15 min. Then the reaction mixtures were centrifuged
at 2,000 rpm for 15 min. Without disturbing the cell pellet, 100 µl
of supernatant from each glass tube were taken in triplicate in a
96-well plate and absorbance was measured at 540 nm.
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the fluorescence intensity in the corresponding cell lysates
(Fig. 1D). Fluorescence intensity in cells incubated with
0.25, 0.5,1, 5, and 10 µM of NBD-cholesterol were observed
to be several-fold higher than the background level.

Fig. 1. Solubilization of NBD-cholesterol/lyso-PtdCho micelles:
Cholesterol (unlabeled) and NBD-cholesterol were mixed together
and solubilized in presence of lyso-PtdCho to form mixed micelles.
(A) Solubilization of cholesterol and NBD-cholesterol in presence
of increasing concentrations of lyso-PtdCho. (B) Solubilization of
NBD-cholesterol is inhibited by cholesterol in a concentration-dependent manner. (C) Concentration-dependent increased uptake
of fluorescent cholesterol by RAW 264.7 macrophages. Cells were
treated with mixed micelles containing 0–10 µM NBD-cholesterol;
after 18 h, cells were visualized under fluorescence microscope
(40× objectives). (D) Cells treated as above were lysed using methanol, and fluorescence intensity was measured using fluorescence
plate reader. (E) Cells were treated with cholesterol and NBD-cholesterol/lyso-PtdCho mixed micelles for 0–48 h, and then fluorescence intensity in the cell lysate was measured. Values are expressed
as mean ± SD (n ⭓ 3). **P < 0.01, ***P < 0.005 (one-way ANOVA
with Dunnett’s multiple comparison test).

of NBD-cholesterol for 18 h. Then the cells were washed
with PBS twice and visualized under fluorescence microscope (Fig. 1C). Macrophages showed concentration-dependent increased accumulation of NBD-cholesterol in
the cytoplasm, which was further confirmed by measuring
3362
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Mixed micelles of cholesterol in aqueous
solution are stable
Mixed micelles of cholesterol, NBD-cholesterol, and
lyso-PtdCho in PBS was prepared as described before, and
aliquots of the filtrate were stored at room temperature,
4°C, and ⫺20°C. Fluorescence intensity of the filtrate from
each storing condition was determined at week 0, week 1,
week 2, and week 4 from the storage time. A mixed micelle
solution from each temperature was filtered again immediately before its use to measure fluorescence intensity or
to treat the cells. We observed that the fluorescence intensity of the solution stored at room temperature started deteriorating rapidly, while the fluorescence intensity of the
solutions stored at 4°C and ⫺20°C was fairly stable for up
to four weeks (Fig. 2A). Furthermore, the mixed micelles
stored at ⫺20°C for four weeks were used to develop macrophage foam cells (Fig. 2B). Fluorescent cholesterol accumulation in the macrophages was documented by taking
images under fluorescence microscope, and droplets of
CE were identified by Oil Red O staining.
Fluorescent cholesterol accumulation was further quantified by measuring fluorescence intensity in the cell lysates
(Fig. 2C), and the accumulated CE droplets were quantified by eluting the Oil Red O stain (Fig. 2D). Measurement of fluorescence intensity and elution of Oil Red O
stain confirmed the previous observations regarding the
stability of mixed micelles at different temperatures. Cells
treated with micelles stored at 4°C and ⫺20°C showed almost no change in NBD-cholesterol or CE droplet accumulation from the starting time point (week 0). However,
there was a sharp decrease in the accumulation of NBDcholesterol and CE droplets in cells treated with micelles
stored at room temperature.

Downloaded from www.jlr.org at UNIV OF CENTRAL FLORIDA, on March 19, 2019

Mixed micelles-mediated cholesterol uptake is a
quick process
RAW 264.7 macrophages were incubated with cholesterol
(unlabeled and NBD-cholesterol)/lyso-PtdCho mixed micelles for 0, 2, 4, 6, 12, 18, 24, and 48 h. Cells for each treatment condition were incubated with 90 µM cholesterol,
300 nM NBD-cholesterol, and 90 µM lyso-PtdCho (15 µl
of mixed micelles/500 µl of medium). At the end of
each time point, cells were observed under microscope
(data not shown) and were lysed to quantify fluorescence
intensity in the cell lysates. It was observed that within 2 h,
the fluorescence intensity of the cells treated with mixed
micelles increased significantly from the background level.
Furthermore, fluorescence intensity in cell lysates after
treatment for 4 h increased slightly from 2 h and almost
reached a plateau between 4 h and 18 h. However, after a
steady increase in fluorescence intensity at 24 h, there was
a sharp decrease in fluorescence intensity level at the 48 h
time point even though it was still several-fold higher than
the background level (Fig. 1E).
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Fig. 2. Stability of NBD-cholesterol/lyso-PtdCho micelles. (A)
Cholesterol and NBD-cholesterol/lyso-PtdCho mixed micelles
were stored at room temperature, 4°C, and ⫺20°C for weeks
0–4, and the fluorescence intensity of the micellerized NBDcholesterol solution stored at different temperatures for up to four
weeks was measured. (B) Foam cells containing NBD-cholesterol
were developed by incubating macrophages with mixed micelles
stored at ⫺20°C for four weeks. (C) Cells were treated with fluorescently labeled mixed micelles stored at room temperature,
4°C, and ⫺20°C for weeks 0–4, and then fluorescence intensity
in the cell lysates was measured. (D) Absorbance value of Oil Red
O stain eluted after staining the cells as treated above. (E) Choles3
terol, H-cholesterol/lyso-PtdCho mixed micelles were stored at
room temperature, 4°C, and ⫺20°C for weeks 0–4, and then radioactivity of the micellerized cholesterol solution stored at different temperatures for up to four weeks was measured (CPM
values converted into nmol of cholesterol). (F) cells were treated
3
with H-cholesterol-labeled mixed micelles stored at room temperature, 4°C, and ⫺20°C for weeks 0–4, and then incorporation of
cholesterol in the CE fraction was measured. (G) Incorporation of
cholesterol in the total extracted lipid after the treatment of cells
was measured as mentioned above. Values are expressed as mean ±
SD (n ⭓ 3). *P < 0.05, **P < 0.01, ***P < 0.005 (one-way ANOVA
with Dunnett’s multiple comparison test). Significant differences
in values for different storage temperatures and time points are
compared with week 0 value.

Mixed micelles mediated cholesterol uptake does not
cause cell cytotoxicity
The amount of lactate dehydrogenase secreted into the
medium during the incubation of cells with cholesterol (or
CE)/lyso-PtdCho mixed micelles was measured to rule out
the cytotoxic effect of the mixed micelles (Fig. 3A). Mixed
micelles contained 3 mM lyso-PtdCho alone, 3 mM cholesterol, or CE with equimolar lyso-PtdCho. Macrophages were
seeded in 96-well plates in 1 × 105/well concentration, and
after 24 h, were washed with PBS twice and incubated with
120 µl of RPMI containing 0.1% LPDS for 4 h. Cell were
then incubated with 1 µg ac-LDL per well (Fig. 3A, bar 2);
50 µM (2 µl from 3 mM lyso-PtdCho containing mixed micelles) and 75 µM (3 µl) lyso-PtdCho micelles per well (Fig. 3A,
bars 3 and 4); 50 µM (2 µl from 3 mM cholesterol/lysoPtdCho containing mixed micelles) and 75 µM (3 µl) cholesterol/lyso-PtdCho mixed micelles per well (Fig. 3A, bars
5 and 6); and 25 µM (1 µl from 3 mM CE/lyso-PtdCho containing mixed micelles) and 50 µM (2 µl) CE/lyso-PtdCho
mixed micelles per well (Fig. 3A, bars 7 and 8) for 18 h. All
the treatments were done in triplicate, and at the end of
18 h, 100 µl of medium was collected from each well to measure LDH activity in the sample. In this colorimetric assay,
pink formazan was measured. Cells incubated with lysoPtdCho micelles produced a very dark-pink color, indicating very high cell lysis, whereas cells treated with cholesterol
or CE/lyso-PtdCho mixed micelles produced a very pale
pink color, as was observed in the cells without any treatment. Thus, cells treated with cholesterol or CE/lyso-PtdCho
mixed micelles were devoid of toxicity.
Cytotoxic effects of lyso-PtdCho are greatly reduced by
the presence of cholesterol in mixed micelles
RBC diluted in saline were mixed with lyso-PtdCho micelles or cholesterol/lyso-PtdCho or CE/lyso-PtdCho mixed
Method for reverse cholesterol transport
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To substantiate the observations regarding the stability
of mixed micelles, additional experiments were performed.
Mixed micelles were prepared using cholesterol (unlabeled and 3H-cholesterol) and lyso-PtdCho, and filtered
micelles were stored as described in the previous section.
Measurements of radioactivity in the micelles stored at
room temperature, 4°C, and ⫺20°C were done at week 0,
week1, week 2, and week 4. Micelles stored under these
conditions were further used to incubate RAW 264.7 macrophages for 18 h. Each time before using, the micelles
stored at different temperatures were filtered through
0.22 µm filter. Stability of the 3H-cholesterol-containing
micelles (Fig. 2E) mimicked the results of micelles containing NBD-cholesterol. More interestingly, cells treated
with 40 µl (per milliliter of medium) of 3H-cholesterolcontaining micelles stored at room temperature showed
steadily decreasing incorporation of cholesterol in total
extracted lipid (Fig. 2G) as well as in CE fraction (Fig. 2F).
Incorporation of cholesterol in total extracted lipid (Fig. 2G)
and in CE fraction (Fig. 2F) remained almost the same as
that of the freshly prepared micelles when cells were treated
with micelles stored at 4°C and ⫺20°C even after four
weeks (TLC plate, supplementary Fig. I).
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and optical density value of the supernatant of the reaction
mixtures was barely above the background level. Nevertheless,
the hemolytic properties of CE/lyso-PtdCho mixed micelles
were in between the other two micelles. At lower concentrations of 10–100 µM, CE/lyso-PtdCho did not cause very
significant amount of hemolysis, even though the amount
of hemolysis was higher than that induced by cholesterol/
lyso-PtdCho mixed micelles. There was a sharp increase in
the level of hemolysis in the reaction mixtures containing
more than 100 µM CE/lyso-PtdCho mixed micelles. At 150–
250 µM concentrations, levels of hemolysis caused by CE/
lyso-PtdCho mixed micelles were almost the same as those
of lyso-PtdCho micelles (Fig. 3B).

Fig. 3. Foam cells developed using cholesterol or CE (unlabeled)/lyso-PtdCho mixed micelles without inducing cytotoxic effects. (A) Lactate dehydrogenase secreted in the medium was used
to quantify LDH activity (µU/ml) in samples treated under different
conditions: no treatment, 1 µg ac-LDL, 50 and 75 µM lyso-PtdCho
micelles, or cholesterol/lyso-PtdCho micelles, 25 and 50 µM CE/
lyso-PtdCho micelles per well. P values for samples treated with
lyso-PtdCho alone were calculated against control (no treatment).
For samples treated with cholesterol or CE/lyso-PtdCho, mixed micelles were calculated against the samples treated with lyso-PtdCho
alone. Values are expressed as mean ± SD (n ⭓ 3). *** P < 0.005,
###
P < 0.005 (one-way ANOVA with Bonferroni’s multiple comparison test). (B) Hemolysis of human RBC was demonstrated by adding increasing concentrations of lyso-PtdCho micelles, cholesterol/
lyso-PtdCho, or CE/lyso-PtdCho mixed micelles to constant concentration of RBC, and then the optical density of the reaction
14
mixture was measured. (C) Metabolism of C-lyso-PtdCho used as
the component of cholesterol/lyso-PtdCho micelles is shown. Values are expressed as mean ± SD (n ⭓ 3). ***P < 0.005 (two-tailed
Student t-test).

micelles containing 0, 10, 25, 50, 100, 150, 200, and 250 µM
of lyso-PtdCho or cholesterol or CE. Cholesterol and CE
containing mixed micelles also had equimolar concentrations of lyso-PtdCho. The reaction mixture containing
lyso-PtdCho micelles showed almost immediate hemolysis,
and optical density value of the supernatant of the reaction mixtures was several-fold higher when compared with
the background level. Conversely, reaction mixture containing cholesterol/lyso-PtdCho mixed micelles showed
almost no hemolysis, even at the end of 15 min incubation,
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Foam cells are developed by incubating macrophages
with cholesterol containing mixed micelles
RAW 264.7 macrophages and mouse peritoneal macrophages were incubated with mixed micelles (40 µl of cholesterol/lyso-PtdCho micelles/ml of medium or 24 µl of
CE/lyso-PtdCho mixed micelles/ml of medium) for 18 h.
Cholesterol/lyso-PtdCho mixed micelles contained 120 µM
cholesterol (unlabeled), 400 nM NBD cholesterol, and
120 µM lyso-PtdCho (Fig. 4A iii,RAW macrophages, and vi,
mouse peritoneal macrophages), whereas CE/lyso-PtdCho
mixed micelles had 72 µM unlabeled CE, 240 nM fluorescently labeled CE, and 72 µM lyso-PtdCho (Fig. 4A iv, RAW
macrophages, and vii, mouse peritoneal macrophages).
ac-LDL (10 µg/ml, Fig. 4A ii) treated RAW macrophages
were used as positive control for all the foam cell development studies. Macrophages incubated with cholesterol/
lyso-PtdCho micelles were provided with 40 µM oleic acid
to aid CE conversion and accumulation. When observed
under the fluorescence microscope, cells treated with
NBD-cholesterol containing mixed micelles showed fluorescent cholesterol accumulation within the cells. As expected negative control cells (Fig. 4A, i and v) and cells
treated with ac-LDL (Fig. 4A, ii) did not yield any fluorescent images. To ensure the accumulation of fluorescent
cholesterol was only within the cells, we lysed RAW 264.7
macrophages and measured the fluorescence intensity in
the cell lysate. Fluorescence intensity in the cell lysates of
negative control was comparable to that of the background
level, whereas fluorescence intensity was much higher in
the lysate of cells incubated with mixed micelles (data not
shown).
CE droplet accumulation in RAW 264.7 macrophages
was demonstrated by Oil Red O staining following the
treatment with ac-LDL, cholesterol/lyso-PtdCho, and CE/
lyso-PtdCho mixed micelles. Oil Red O stain was eluted
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lyso-PtdCho component of mixed micelles was
metabolized into PtdCho
Cells treated with cholesterol/lyso-PtdCho (unlabeled
and 14C-lyso-PtdCho) mixed micelles for 18 h demonstrated that more than 75% of lyso-PtdCho provided as the
component of mixed micelles was metabolized into PtdCho
(Fig. 3C). The metabolization of lyso-PtdCho to PtdCho
was a very quick process, which took place within 2 h (data
not shown) as demonstrated previously (50, 51).
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Fig. 4. Foam cells developed using mixed micelles show cholesterol esterification. (A) RAW 264.7 (i–iv)
and mouse peritoneal macrophages (v–vii) incubated with mixed micelles for 18 h show accumulation of
NBD-cholesterol (iii, RAW 264.7 macrophages; vi, mouse peritoneal macrophages) and fluorescent CE (iv,
RAW 264.7 macrophages; vii, mouse peritoneal macrophages) droplets under fluorescent microscope. CE
droplet accumulation is demonstrated by Oil Red O staining. CE droplet accumulation was observed in cells
treated with ac-LDL (ii, RAW 264.7 macrophages), cholesterol (iii, RAW 264.7 macrophages; vi, mouse peritoneal macrophages), or CE (iv, RAW 264.7 macrophages; vii, mouse peritoneal macrophages)/lyso-PtdCho
mixed micelles. (B) Oil Red O stain from RAW 264.7 macrophages treated with ac-LDL and cholesterol/
lyso-PtdCho or CE/lyso-PtdCho mixed micelles were eluted and absorbance was measured. (C) cells were
3
3
treated with H-cholesterol-labeled ac-LDL or cholesterol, H-cholesterol/lyso-PtdCho mixed micelles and
incorporation of cholesterol in total extracted lipid was measured. (D) Incorporation of cholesterol in CE
fraction was measured following the treatment above. (E) Cells incubated with cholesterol or CE/lyso14
PtdCho mixed micelles were supplied with 40 µM C-oleic acid/ml. Cells incubated with CE/lyso-PtdCho mixed
14
micelles showed almost 10-fold less C-oleic acid incorporation than those treated with cholesterol/lyso14
PtdCho mixed micelles. Insert shows radioautograph image of C-oleic acid incorporation in CE fraction of
cells as treated above. Values are expressed as mean ± SD (n ⭓ 3). **P < 0.01 (two-tailed Student t-test).
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after the images were taken. Eluted Oil Red O stain, which
indirectly quantifies the amount of CE droplets present in
the cells, was taken in 100 µl aliquots and absorption was
measured at 500 nm. Optical density value of all the three
samples matched very closely and ranged 0.3–0.4 (Fig. 4B).

Cholesterol is esterified into CE during micelle mediated
foam cell formation
RAW 264.7 macrophages incubated with cholesterol/lysoPtdCho mixed micelles were simultaneously treated with
14
C-oleic acid to study the incorporation of radioactive
oleate during the esterification of cholesterol into CE.
Oleic acid (40 µM with 200 pCi radioactivity/ml of medium)
was supplied during the incubation of cells with cholesterol
or CE/lyso-PtdCho mixed micelles, and after overnight incubation, lipids were extracted using methanol/chloroform
(2:1). TLC separation of the samples from both types of
micelle treatments showed distinct spots of CE when compared with the standard CE spot, and these spots were further analyzed for radioactivity. Before exposing the TLC
plate to iodine vapor, a radioautograph image of the TLC
plate was taken, and the image clearly showed much higher
oleate incorporation in cells incubated with cholesterol/
lyso-PtdCho micelles (Fig. 4E, insert). This observation was
further confirmed when analysis of oleate incorporation
in CE showed that cells incubated with CE/lyso-PtdCho
micelles had a 10-fold percentage decrease in 14C-oleic acid
incorporation in CE compared with cells treated with cholesterol/lyso-PtdCho micelles (Fig. 4E).
Uptake of cholesterol micelles is distinct from
that of ac-LDL
Fucoidan and polyinosinic acid are ligands for scavenger receptor A1 (SR-A1), and they reduce or inhibit the
uptake of ac-LDL by macrophages (52, 53). However, fucoidan or polyinosinic acid did not inhibit the accumulation of fluorescent cholesterol or CE in RAW 264.7
macrophages (Fig. 5A, B). Fucoidan (50 µg/ml) and
polyinosinic acid (100 µg/ml) were used separately to
block ac-LDL-mediated foam cell formation. Oil Red O
staining demonstrated that macrophages preincubated
with fucoidan or polyinosinic acid accumulated very little
to no CE droplets when treated with ac-LDL. But under the
same conditions, macrophages incubated with cholesterol
3366
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Fig. 5. Mixed micelle-mediated foam cell formation is not affected
by scavenger receptor binding ligands. (A) Macrophages were preincubated with either 50 µg/ml fucoidan or 100 µg/ml polyinosinic
acid, followed by incubation with cholesterol or CE (unlabeled and
fluorescently labeled)/lyso-PtdCho mixed micelles for 18 h. NBDcholesterol or fluorescent CE accumulation within macrophages was
observed in the cells preincubated with fucoidan and polyinosinic
acid. (B) Measurement of fluorescence intensity in cell lysates from
cells treated with fluorescently labeled cholesterol or CE with or
without fucoidan or polyinosinic acid treatment. (C) Macrophages
preincubated with fucoidan and polyinosinic acid show very little to
no CE droplet accumulation after treatment with ac-LDL (i). CE
droplet accumulation in macrophages preincubated with fucoidan
and polyinosinic acid was observed after incubation with cholesterol
(ii) or CE (iii)/lyso-PtdCho mixed micelles. (D) Oil Red O stain was
eluted from the cells treated with ac-LDL and cholesterol or CE/
lyso-PtdCho mixed micelles with or without the preincubation of
fucoidan or polyinosinic acid, and then absorption of Oil Red O stain
at 500 nm was measured. Values are expressed as mean ± SD (n ⭓
3). ***P < 0.005 (one-way ANOVA with Dunnett’s multiple comparison test). Significant differences for fucoidan and polyinosinic treatment are compared with the respective positive control.
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Quantity of CE accumulated in foam cells developed by
ac-LDL mediated uptake or mixed micelles mediated
uptake are similar
RAW 264.7 macrophages were treated with 10 µg/ml of
ac-LDL labeled with 3H-cholesterol or with cholesterol
(unlabeled and 3H-cholesterol)/lyso-PtdCho mixed micelles
for 18 h. Quantification of cholesterol incorporation in total
extracted lipid showed that foam cells developed by ac-LDLmediated and mixed micelles-mediated uptake contained
22 nmol and 26 nmol of cholesterol (volume of total extracted lipid was 50 µl), respectively (Fig. 4C). Cholesterol
incorporation in the CE fraction of extracted lipid was
1.5 nmol for ac-LDL-mediated foam cell development and
1.8 nmol for that of mixed micelles (Fig. 4D).
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HDL causes cholesterol efflux from foam cells
Foam cells were developed by incubating RAW 264.7
macrophages and mouse peritoneal macrophages with
cholesterol (unlabeled and NBD-cholesterol or 3H cholesterol)/lyso-PtdCho mixed micelles and used for the efflux
study in presence of HDL. Foam cells were incubated with
0, 25, 50, 100, and 200 µg/ml of freshly prepared HDL.
After 4 h, medium was collected from each well and RAW
264.7 macrophages were lysed to measure the presence of
NBD-cholesterol in the medium and in the cell lysates, respectively. Fluorescence intensity in the medium collected
from foam cells alone (no HDL) was in the background
level and increased in a HDL concentration-dependent
manner (Fig. 7A). A similar observation was made with
respect to cholesterol efflux when mouse peritoneal macrophages were used (Fig. 7A, insert). Inversely, the fluorescence intensity in the lysate of foam cells without HDL
incubation was the maximum. Fluorescence intensity in
the lysate of foam cells decreased gradually as the concentration of HDL in the medium increased (Fig. 7B). Images
were taken under fluorescence microscope after the incubation of foam cells with or without HDL. Reduction in
fluorescence intensity indicated that less NBD-cholesterol
remained inside the foam cells when they were incubated
with increasing concentrations of HDL. Study of CE droplet accumulation by Oil Red O staining further confirmed
our observations (Fig. 7C).
These results were further validated in the efflux study
using 3H-cholesterol. CPM value for 3H-cholesterol efflux
was converted into nanomoles (Fig. 8A). Further analysis
showed that 25–200 µg of native HDL caused cholesterol
efflux ranging 10–25% of cholesterol present in total extracted lipid (Fig. 8B). Preliminary results indicated that
most of the cholesterol in the medium was associated with
intact, reisolated HDL (data not shown).

HDL-mediated cholesterol efflux is quantitatively similar
to foam cells developed by ac-LDL and mixed micelles
3
Foam cells developed by H-cholesterol labeled ac-LDL
and cholesterol (unlabeled and 3H-cholesterol)/lyso-PtdCho
mixed micelles were incubated with 0, 25, and 50 µg of native HDL for 4 h. Quantitatively, the cholesterol efflux by
25 and 50 µg of HDL from foam cells developed by mixed
micelles were a little bit higher than that from ac-LDLderived foam cells (Fig. 8C). However, when the percentage of cholesterol efflux was calculated with respect to
cholesterol present in total extracted lipid, the efflux rate
was very similar. Incubation with 25 and 50 µg of HDL
caused 2- and 3-fold induction in cholesterol efflux from
foam cells developed from either method of cholesterol
loading (Fig. 8D).
ox-HDL fails to cause cholesterol efflux
Cholesterol efflux from foam cells were compared in
the presence of 25 µg and 50 µg native HDL and MPO and
Cu-mediated ox-HDL. Cholesterol efflux was documented
by measuring the fluorescence intensity in medium after
incubation of foam cells with 25 µg and 50 µg native HDL
and ox-HDL. Even though Cu-ox-HDL caused some cholesterol efflux, 25 µg and 50 µg native HDL induced much
higher cholesterol efflux when compared with that of
ox-HDL counterparts (Fig. 7D). As seen in Fig. 7D, MPOmediated oxidation of HDL was more effective at inhibiting cholesterol efflux than was Cu-mediated oxidation.
Cholesterol efflux in presence of ox-HDL was further confirmed by using NBD-cholesterol-loaded mouse peritoneal
macrophages (Fig. 7E) and 3H-cholesterol-loaded foam
cells (data not shown).

DISCUSSION
In this study, we demonstrated for the first time that macrophage foam cells can be developed using micellerized
cholesterol or CE. The foremost challenge to incorporate
cholesterol in cells is obviously its high hydrophobicity.
The amphiphilic property of lyso-PtdCho, which is also a
natural detergent, was utilized to form mixed micelles and
to solubilize cholesterol and CE (unlabeled and fluorescently labeled) in PBS. A previous study demonstrated that
lyso-PtdCho could form a stable, soluble complex with
equimolar cholesterol (54), and this technique has been
modified successfully to solubilize ␤-carotene in aqueous
solution (32). Augé et al. (32) further demonstrated that
solubilized ␤-carotene could be utilized for cellular enrichment of ␤-carotene in vitro. In the present study, increasing
amounts of cholesterol (unlabeled and NBD-cholesterol)
were successfully solubilized in PBS by gradually raising
the concentration of lyso-PtdCho in the mixed micelles.
Solubility of NBD-cholesterol was demonstrated directly
by measuring the fluorescence intensity of the aqueous
solution. We validated the solubility of cholesterol in aqueous solution indirectly by reducing the solubility of NBDcholesterol in a cholesterol concentration-dependent
manner. As the concentration of cholesterol provided to
make mixed micelles was gradually increased while keeping
Method for reverse cholesterol transport
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(or CE)/lyso-PtdCho mixed micelles accumulated plenty
of CE droplets (Fig. 5C).
Quantification of CE droplet accumulation by Oil Red
O stain elution further established this observation. While
the optical density of stains eluted from cells treated with
ac-LDL following preincubation with fucoidan or polyinosinic acid decreased by 2-fold from the positive control, the
same preincubation had little or no effect on the CE droplet accumulation in cells treated with cholesterol or CE/
lyso-PtdCho mixed micelles (Fig. 5D).
The unique nature of foam cell development by mixed
micelles was further established by using 3H-cholesterollabeled ac-LDL and mixed micelles. Pretreatment of fucoidan and polyinosinic acid decreased the incorporation
of cholesterol both in total extracted lipid and in a CE
fraction by 4- and 2-fold, respectively, in the case of acLDL-mediated foam cell development. Fucoidan and
polyinosinic acid did not have any effect on the incorporation of cholesterol in total extracted lipid or in the CE
fraction (TLC plate, supplementary Fig. III) when foam
cell development was mediated by cholesterol (unlabeled and 3H-cholesterol)/lyso-PtdCho mixed micelles
(Fig. 6A, B).
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3

the concentration of NBD-cholesterol constant, the fluorescence intensity of the aqueous solution was decreased
in a concentration-dependent manner. RAW 264.7 macrophages were loaded with NBD-cholesterol and unlabeled
cholesterol in a concentration-dependent manner, and
fluorescently labeled, cholesterol-enriched foam cells were
developed. Foam cells were successfully generated by using
mouse peritoneal macrophages as well. We also observed
that mixed micelle mediated NBD-cholesterol uptake is a
very rapid process; cells were enriched with NBD-cholesterol
within 2 h continuing up to 24 h. Nonetheless, there was a
sharp decline in the fluorescence intensity level at 48 h,
which was due to detachment of many cells as a result of
overconfluence.
Previous studies demonstrated that NBD-cholesterol has
a higher aqueous solubility than cholesterol and might not
truly represent the uptake and efflux of cholesterol (40).
Higher solubility of NBD-cholesterol has been utilized
for uptake studies by directly incubating cells with NBDcholesterol in ethanol solution (29, 40). The influence of
higher solubility of NBD-cholesterol in the results of cholesterol uptake and efflux studies was ruled out by using
3
H-cholesterol, a more widely used cholesterol analog to
repeat the key experiments. Recently, Khera et al. (28)
and Li et al. (15) utilized macrophages labeled with free
radioactive cholesterol for high-throughput cholesterol efflux studies. The enrichment of macrophages with free
3368
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Fig. 6. Incorporation of cholesterol is not inhibited by preincubation with fucoidan or polyinosinic acid. (A) RAW 264.7 mac3
rophages were treated with H-cholesterol labeled ac-LDL or
3
cholesterol, H-cholesterol/lyso-PtdCho mixed micelles with or
without fucoidan and polyinosinic acid preincubation, and then
incorporation of cholesterol in total extracted lipid was measured.
(B) incorporation of cholesterol in CE fraction was measured from
cells as treated above. Values are expressed as mean ± SD (n ⭓ 3).
**P < 0.01, ***P < 0.005 (one-way ANOVA with Dunnett’s multiple
comparison test). Significant differences for fucoidan and polyinosinic treatment are compared with the respective positive control.

14

H-cholesterol or C-cholesterol was done by incubating
cells with free radioactive cholesterol for 24 h. However,
the goal of our present study was to develop foam cells
enriched with cholesterol and CE, not just with fluorescent or radiolabeled cholesterol, by a novel, reproducible,
quick technique. Therefore, lyso-PtdCho micelle-mediated
cholesterol delivery was a more suitable approach to solubilize and to ensure the delivery of highly hydrophobic cholesterol and CE to the cells. In addition, we documented
that the free cholesterol delivered by micelles gets esterified to CE and produces CE droplet-enriched foam cells.
It is also to be noted that cellular cholesterol efflux is also
accompanied by cellular phospholipid efflux. As demonstrated in our studies, lyso-PtdCho is efficiently converted to
PtdCho and thus would provide the PtdCho needed for
efficient efflux. It remains to be established whether the
fluorescence/radioactivity of both cholesterol and PtdCho
are associated with the HDL fraction in the medium. Our
preliminary results (data not shown) suggest that most of
the fluorescence in the medium is associated with isolated
HDL after incubation with foam cells containing NBDcholesterol.
Incorporation of 14C oleate was studied to ascertain that
esterification of cholesterol into CE is indeed the source
of lipid droplets seen inside the foam cells upon incubation with cholesterol/lyso-PtdCho micelles. Cells incubated with cholesterol/lyso-PtdCho micelles yielded the
CE band comparable to one from CE/lyso-PtdCho micelletreated cells upon TLC separation (supplementary Fig. II).
Nonetheless, cholesterol/lyso-PtdCho micelle-treated cells
showed very high 14C oleic acid incorporation, while CE/
lyso-PtdCho micelle-treated cells had a 10-fold reduction
in oleate incorporation. This demonstrated that cholesterol/
lyso-PtdCho mixed micelles generated foam cells, which
would be physiologically relevant, as cholesterol was esterified into CE and appeared as lipid droplets during Oil Red
O staining. For all the experiments involving cholesterol
3
(unlabeled and NBD or H-cholesterol)/lyso-PtdCho micelles, cells were incubated with 40 µM oleic acid along
with the micelles. Oleic acid was supplied to facilitate the
esterification of cholesterol into CE and has been used in
many studies to follow ac-LDL uptake.
lyso-PtdCho is known to induce cell lysis due to its
detergent-like properties, and it causes cell lysis by breaking
down the intact cell membrane (54–56). It was observed in
the current study that lyso-PtdCho alone is highly soluble
in PBS, and it caused massive cell death. Cell lysis was confirmed by measuring secretion of LDH in medium upon
incubation of cells with lyso-PtdCho micelles. However,
cell morphology was not affected by the incubation with
cholesterol/lyso-PtdCho mixed micelles, as is clearly demonstrated (Fig. 4A, iii). We also showed that red blood cells
(RBC) were resistant to lysis when increasing concentrations of cholesterol were present along with lyso-PtdCho.
This observation was not surprising, as the work of Rand
et al. (54) explained that a stable complex between equimolar cholesterol and lyso-PtdCho causes a conformational
change in micelle formation, leading to reduction in the
destabilizing and lytic effects of lyso-PtdCho. The reduced
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lytic effects of cholesterol/lyso-PtdCho mixed micelles were
clearly established by its reaction with RBCs. After incubation of RBC with lyso-PtdCho micelles for 15 min, lysed
RBC released hemoglobin in the aqueous solution, while
the same reaction with an equivalent amount of cholesterol/lyso-PtdCho mixed micelles showed very little or no
cell lysis. Nonetheless, CE/lyso-PtdCho mixed micelles induced more cell lysis, causing increased secretion of LDH
(data not shown) in the medium and hemoglobin in the
aqueous solution when compared with that of cholesterol/
lyso-PtdCho. One possible explanation could be that CE
does not cause the conformational changes that cholesterol

does during mixed micelle formation, and thus, CE is less
effective in reducing the lytic effects of lyso-PtdCho. After
this initial observation, reduced volume of CE/lyso-PtdCho
mixed micelles was used to enrich macrophages with CE.
Lytic effects of lyso-PtdCho micelles were clearly in effect
even with the concentration as low as 10 µM of lyso-PtdCho,
while presence of CE up to a concentration of 100 µM
greatly reduced this lytic effect.
The advantage of using lyso-PtdCho as a membrane fusion agent to deliver cholesterol to cells is 2-fold: lyso-PtdCho
is metabolized by cells into PtdCho (an acylation reaction)
and into glycerophosphorylcholine (a transesterification
Method for reverse cholesterol transport
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Fig. 7. Cholesterol efflux from foam cells in presence
of HDL. Foam cells were developed using cholesterol
3
(unlabeled and NBD-cholesterol or H-cholesterol)/
lyso-PtdCho mixed micelles. Foam cells were incubated with 0–200 µg/ml of HDL for 4 h. (A) Medium
from NBD-cholesterol containing foam cells (RAW
264.7 macrophages) incubated with increasing concentrations of HDL showed concentration-dependent
increase in fluorescence intensity. Insert shows mouse
peritoneal macrophage-derived foam cells incubated
with HDL demonstrate concentration-dependent
NBD-cholesterol efflux in the medium. (B) Fluorescence
intensity in the corresponding cell lysates decreases
as the concentration of HDL increases. *P < 0.05; **P <
0.01, ***P < 0.005 (one-way ANOVA with Dunnett’s
multiple comparison test). (C) Fluorescence images
and Oil Red O staining show reduction in CE droplet
accumulations in cells after incubation with HDL. (D)
Foam cells were incubated with 25 and 50 µg/ml of
native HDL and MPO or Cu-mediated ox-HDL. Cholesterol efflux caused by native HDL was much higher
when compared with the same concentration of oxHDL. Values are expressed as mean ± SD (n ⭓ 3). ***P <
0.005 (one-way ANOVA with Dunnett’s multiple comparison test). Significant differences for ox-HDL
treatments are compared with the corresponding concentration of native HDL. (E) Cholesterol efflux from
peritoneal macrophage-derived foam cells incubated
with 25 and 50 µg/ml of native HDL and MPO-mediated ox-HDL. Values are expressed as mean ± SD (n ⭓
3). ***P < 0.005 (two-tailed Student t-test).
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reaction) (50). Previous studies demonstrated this conversion using various cell lines, including macrophages (51).
The quick metabolism of lyso-PtdCho by cells ensures successful cargo delivery to the cells without influencing RCT.
We observed that more than 75% of lyso-PtdCho delivered
as mixed micelles was metabolized into PtdCho within 2 h
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Fig. 8. ac-LDL and mixed micelle-mediated foam cells demonstrate similar HDL-dependent cholesterol efflux. (A) foam cells de3
veloped by incubation with H-cholesterol containing mixed micelles
showed concentration-dependent increase in cholesterol efflux
when treated with increasing concentrations of HDL. (B) HDL-mediated cholesterol efflux was represented as percentage of cholesterol incorporated in total extracted lipid. (C) Foam cells were
3
developed by incubating macrophages with H-cholesterol labeled
3
ac-LDL or H-cholesterol containing mixed micelles, and HDLmediated cholesterol efflux was studied using 25 and 50 µg/ml of
native HDL. (D) HDL-mediated cholesterol efflux represented as
percentage of cholesterol incorporated in total extracted lipid. Values
are expressed as mean ± SD (n ⭓ 3). **P < 0.01, ***P < 0.005 (oneway ANOVA with Dunnett’s multiple comparison test).

of incubation of cells with cholesterol/lyso-PtdCho (unlabeled and 14C-tagged) mixed micelles.
We further established that micellerized CE uptake is
uniquely distinguished from ac-LDL uptake. SR-A1 is actively
involved in ac-LDL binding and ac-LDL mediated uptake of
cholesterol (52). We used fucoidan and polyinosinic acid,
known ligands for SR-A1 (53), to inhibit the binding of acLDL to SR-A1. As expected, fucoidan and polyinosinic acid
prevented the ac-LDL-mediated foam cell formation and
greatly inhibited the incorporation of 3H-cholesterol in total
extracted lipid and in the CE fraction of lipids in ac-LDLtreated cells. However, SR-A1 ligands had no effect on cholesterol or CE/lyso-PtdCho mixed micelle-mediated cholesterol
delivery, and the accumulation of NBD-cholesterol remained
unaffected. Additionally, fucoidan and polyinosinic acid had
no inhibitory effect on the incorporation of 3H-cholesterol
in total extracted lipid or on the CE fraction of lipids when
macrophages were incubated with cholesterol/lyso-PtdCho
mixed micelles. Thus the micelle-mediated cholesterol or
CE delivery utilizes the membrane fusion property of lysoPtdCho, making this foam cell development technique
novel and unique. Furthermore, the universality of micellemediated delivery was established by developing cholesterolenriched hepatocytes, HepG2 cells (data not shown).
Currently the development of foam cells used to study
RCT typically involves isolation and acetylation of LDL, followed by incorporation of radiolabeled cholesterol. Isolation
of LDL is a tedious process, and LDL is prone to be oxidized
automatically during the isolation process (1). Isolation and
acetylation of LDL can vary qualitatively from one preparation to another, resulting in the induction of inflammatory
responses in animal models. Most importantly, ac-LDL
preparations are not stable and cannot be stored for a long
time. In our present study, we established that cholesterol or
CE/lyso-PtdCho mixed micelle preparation is functionally
stable at 4°C and ⫺20°C up to one month and that mixed
micelle preparation stored at ⫺20°C is stable for even longer
time (data not shown). Furthermore, mixed micelle preparation stored at ⫺20°C for one month was used to develop macrophage foam cells, which were qualitatively similar to those
developed with freshly prepared mixed micelles. Quantitative analysis of foam cells developed with mixed micelles
stored at 4°C and ⫺20°C up to one month revealed that storage time did not affect the accumulation of NBD-cholesterol
3
or CE droplets or the incorporation of H-cholesterol in total
extracted lipid or the CE fraction of the lipid. Extraction of
lipids from the mixed micelle preparation stored at 4°C and
⫺20°C for several weeks followed by analysis from TLC separation showed no decrease in lyso-PtdCho and cholesterol
content (data not shown).
We also observed that mixed micelle-mediated cholesterol loading was highly reproducible and the amount of
cholesterol incorporated in the total extracted lipid always
ranged 25–27 nmol when cells were incubated with choles3
terol (unlabeled and H-cholesterol)/lyso-PtdCho mixed
micelles (data not shown). The same treatment resulted in
the incorporation of 1.5–1.8 nmol of cholesterol in CE fraction of the lipid when the experiment was repeated five
times or more (data not shown).
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Foam cells developed by using cholesterol/lyso-PtdCho
mixed micelles were efficiently used to study cholesterol efflux. Increased concentration of HDL caused a concentrationdependent cholesterol efflux from the foam cells and was
quantified by measuring the amount of NBD-cholesterol in
the medium. For the efflux study, foam cells were also developed using cholesterol (unlabeled and 3H-cholesterol)/
lyso-PtdCho mixed micelles, and concentration-dependent
efflux of 3H-cholesterol confirmed our observations using
NBD-cholesterol. HDL-mediated cholesterol efflux from
foam cells developed by mixed micelles was quantitatively
very similar to foam cells developed by ac-LDL. Various
studies have suggested that oxidation of HDL leads to loss
of its antiatherogenic property. To determine whether the
micelle-derived foam cells could be utilized to differentiate
between native, functional HDL and oxidized, dysfunctional HDL, we used equal concentrations of native and oxHDL separately. As we expected, ox-HDL failed to induce
any significant cholesterol efflux from the foam cells. Therefore, we conclude that the foam cells developed by using
cholesterol/lyso-PtdCho mixed micelles potentially can be
used to study RCT in subjects with or without the background of cardiovascular disease.
Development of foam cells loaded with fluorescently labeled cholesterol via mixed micelles mediated technique
would be less time consuming and highly reproducible. Furthermore, these foam cells could be utilized to screen a large
number of human plasma/HDL samples to determine the
efficacy of cholesterol efflux from foam cells or RCT.
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